Managing constipation that's opioid-induced.
Scholz
M
M
Northwest Neuroscience Institute, Seattle, USA.
D000284:Administration, Oral; D000328:Adult; D000701:Analgesics, Opioid / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000150:complications; D002626:Chemistry, Pharmaceutical; D003248:Constipation / Q000139:chemically induced* / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008691:Methadone / Q000009:adverse effects*; D009270:Naloxone / Q000737:chemistry / Q000627:therapeutic use; D009271:Naltrexone / Q000031:analogs & derivatives / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D000644:Quaternary Ammonium Compounds
D000701:Analgesics, Opioid; D009292:Narcotic Antagonists; D000644:Quaternary Ammonium Compounds; C032257:methylnaltrexone; D009270:Naloxone; D009271:Naltrexone; D008691:Methadone